Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)

v3.24.2.u1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Business Acquisition, Contingent Consideration [Line Items]    
Deferred income - ERC $ 10,140 $ 10,140
Goods received not invoiced 5,155 5,019
Accrued employee related expenses and liabilities 5,300 4,175
Operating lease obligations $ 4,416 $ 4,693
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total accrued expenses and other current liabilities Total accrued expenses and other current liabilities
Accrued sales and excise taxes $ 2,474 $ 2,388
Accrued interest 2,094 4,106
Deferred revenue (loyalty program) 1,280 1,407
Accrued professional and management fees 729 986
Accrued capital expenditures 0 702
Other accrued expenses and current liabilities 4,295 5,470
Total accrued expenses and other current liabilities 35,883 44,070
Nature's Remedy    
Business Acquisition, Contingent Consideration [Line Items]    
Other liabilities - non-current 5,000  
Interest payable, noncurrent 2,677  
Acquisition Milestone Accrual    
Business Acquisition, Contingent Consideration [Line Items]    
Contingent consideration liabilities 0 4,167
Thirty-Month Anniversary Contingent Consideration    
Business Acquisition, Contingent Consideration [Line Items]    
Contingent consideration liabilities $ 0 $ 817